Curis Inc (CRIS)

Trade CRIS now with
3/8/2018 7:02:05 AM Curis Q4 Loss Per Share $0.05 Vs Loss $0.08 Prior Year
1/17/2018 7:01:27 AM Curis Announces Initiation Of Phase 1 Trial Of CA-4948
11/7/2017 7:02:04 AM Curis Q3 Net Loss $15.5 Mln Or $0.11/Shr Vs Loss $28.3 Mln Or $0.21/Shr Last Year
9/14/2017 7:01:48 AM Curis Prices Public Offering Of 20 Mln Common Shares
9/13/2017 4:08:49 PM Curis Announces Proposed Public Offering Of Common Stock
9/12/2017 9:28:43 AM Dr. Reddy’s Subsidiary, Curis Announce CA-170 Program Update Following Data Presented At ESMO 2017
9/11/2017 4:03:07 AM Curis And Aurigene Announce CA-170 Program Update; Plan Clinical Trial Of CA-170 In India
8/3/2017 7:09:50 AM Curis Q2 Net Loss $14.1 Mln Or $0.10/Shr Vs Net Loss $11.3 Mln Or $0.09/Shr Last Year
8/1/2017 7:02:50 AM Cara Therapeutics Appoints Mani Mohindru Cas CFO,effective August 15
5/25/2017 7:01:30 AM Curis Reports Presentations Related To CA-170 And CUDC-907 At 2017 ASCO Annual Meeting
5/4/2017 7:05:50 AM Curis Q1 Revenues Rise To $2.1 Mln From $1.7 Mln Last Year; Chairman James McNab Jr. To Retire
4/5/2017 7:01:38 AM Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)